All: Sorry in advance if this is kind of a "simpleton" question, but would it be fair to say we will have a much better idea regarding the future of RVUE in the next 2 weeks?
The final scheduled buy is September, & previous buys were mid-month. It also "appears" RVUE does need the monthly working capital Roche has been providing?
Are these the "main" possibilities:
1) Roche makes the September buy & nothing else is announced. PPS slowly drifts lower until Q3 report.
2) Roche makes the buy & commits to another, new tranche of buys.
3) Roche makes the buy and announces a kick-ass merger of some kind.
4) Something else I'm missing.
Would love to hear the opinions/percentage chances of above.
Also, were the "take out" purchases at .011 (I think) already executed (to take out the prior debt), or could that be coming in October/November as per the filing?
Thanks in advance.